Tealwood Asset Management Inc. Sells 315 Shares of Hologic, Inc. (NASDAQ:HOLX)
Tealwood Asset Management Inc. Sells 315 Shares of Hologic, Inc. (NASDAQ:HOLX)
Tealwood Asset Management Inc. lessened its stake in shares of Hologic, Inc. (NASDAQ:HOLX – Get Rating) by 1.9% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 16,310 shares of the medical equipment provider's stock after selling 315 shares during the period. Tealwood Asset Management Inc.'s holdings in Hologic were worth $1,130,000 at the end of the most recent quarter.
根据蒂尔伍德资产管理公司(Tealwood Asset Management Inc.)向美国证券交易委员会披露的最新信息，该公司在第二季度减持了霍洛奇公司(Sequoia Capital，Inc.)的股份，减持幅度为1.9%。在此期间出售了315股后，该机构投资者持有这家医疗设备提供商的股票16,310股。截至最近一个季度末，蒂尔伍德资产管理公司(Tealwood Asset Management Inc.)持有的霍洛奇股份价值1,130,000美元。
Several other institutional investors and hedge funds have also recently modified their holdings of HOLX. Rockefeller Capital Management L.P. raised its stake in shares of Hologic by 5.2% during the fourth quarter. Rockefeller Capital Management L.P. now owns 9,956 shares of the medical equipment provider's stock valued at $761,000 after acquiring an additional 494 shares in the last quarter. LPL Financial LLC raised its stake in Hologic by 14.0% in the fourth quarter. LPL Financial LLC now owns 194,232 shares of the medical equipment provider's stock worth $14,870,000 after buying an additional 23,884 shares in the last quarter. Alliancebernstein L.P. raised its stake in Hologic by 18.3% in the fourth quarter. Alliancebernstein L.P. now owns 443,062 shares of the medical equipment provider's stock worth $33,921,000 after buying an additional 68,664 shares in the last quarter. Impax Asset Management Group plc raised its stake in Hologic by 2.2% in the fourth quarter. Impax Asset Management Group plc now owns 12,267 shares of the medical equipment provider's stock worth $939,000 after buying an additional 264 shares in the last quarter. Finally, Guggenheim Capital LLC raised its stake in Hologic by 12.9% in the fourth quarter. Guggenheim Capital LLC now owns 78,904 shares of the medical equipment provider's stock worth $6,041,000 after buying an additional 9,031 shares in the last quarter. Institutional investors own 85.70% of the company's stock.
其他几家机构投资者和对冲基金最近也调整了对HOLX的持股。洛克菲勒资本管理公司(Rockefeller Capital Management L.P.)在第四季度将其在霍洛奇公司的股份增加了5.2%。洛克菲勒资本管理公司(Rockefeller Capital Management L.P.)在上个季度增持了494股股票后，现在拥有这家医疗设备提供商9956股股票，价值76.1万美元。LPL Financial LLC在第四季度将其在霍洛奇的持股比例提高了14.0%。LPL Financial LLC现在拥有这家医疗设备提供商194,232股股票，价值14，87万美元，上个季度又购买了23,884股。联合伯恩斯坦公司在第四季度将其在霍洛奇公司的持股比例提高了18.3%。联合伯恩斯坦公司现在持有这家医疗设备提供商443,062股股票，价值33,921,000美元，上个季度又购买了68,664股。Impax Asset Management Group plc在第四季度将其在霍洛奇的持股增加了2.2%。Impax Asset Management Group plc现在持有这家医疗设备提供商12,267股股票，价值93.9万美元，上个季度又购买了264股。最后，古根海姆资本有限责任公司在第四季度将其在霍洛奇公司的持股比例提高了12.9%。Guggenheim Capital LLC现在持有这家医疗设备提供商78,904股股票，价值6,041,000美元，上个季度又购买了9,031股。机构投资者持有该公司85.70%的股票。
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
HOLX has been the subject of a number of recent research reports. Morgan Stanley reduced their price objective on shares of Hologic from $72.00 to $70.00 and set an "equal weight" rating for the company in a research note on Thursday, July 28th. Bank of America downgraded shares of Hologic from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $81.00 to $75.00 in a research note on Wednesday, July 20th. BTIG Research lowered shares of Hologic from a "buy" rating to a "neutral" rating in a report on Monday, July 18th. Finally, UBS Group began coverage on shares of Hologic in a report on Wednesday, July 20th. They issued a "neutral" rating and a $73.00 price target on the stock. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $76.71.
HOLX是最近一些研究报告的主题。7月28日，周四，摩根士丹利在一份研究报告中将霍洛奇股票的目标价从72.00美元下调至70.00美元，并为该公司设定了“同等权重”的评级。在7月20日星期三的一份研究报告中，美国银行将霍洛奇的股票评级从买入下调至中性，并将该股的目标价从81.00美元下调至75.00美元。在7月18日星期一的一份报告中，BTIG Research将霍洛奇的股票评级从“买入”下调至“中性”。最后，瑞银集团在7月20日星期三的一份报告中开始报道霍洛奇的股票。他们对该股给予了“中性”评级和73.00美元的目标价。7名股票研究分析师对该股的评级为持有，4名分析师对该公司的评级为买入。根据MarketBeat.com的数据，该公司的共识评级为持有，共识目标价为76.71美元。
Hologic Stock Performance
霍洛奇股票表现
Hologic (NASDAQ:HOLX – Get Rating) last announced its quarterly earnings data on Wednesday, July 27th. The medical equipment provider reported $0.95 earnings per share for the quarter, beating analysts' consensus estimates of $0.69 by $0.26. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $896.71 million. Hologic had a net margin of 28.93% and a return on equity of 37.48%. The business's quarterly revenue was down 14.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.33 earnings per share. Equities analysts anticipate that Hologic, Inc. will post 5.82 EPS for the current fiscal year.
纳斯达克(HOLX：HOLX-GET Rating)上一次公布季度收益数据是在7月27日星期三。这家医疗设备供应商公布本季度每股收益为0.95美元，比分析师普遍预期的0.69美元高出0.26美元。该公司本季度营收为10亿美元，而分析师预期为8.9671亿美元。霍洛奇的净利润率为28.93%，股本回报率为37.48%。与去年同期相比，该业务的季度收入下降了14.2%。去年同期，该公司每股收益为1.33美元。股票分析师预计，霍洛奇公司本财年每股收益将达到5.82美元。
About Hologic
关于霍洛奇
(Get Rating)
(获取评级)
Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.
霍洛奇公司在美国、欧洲、亚太地区和国际上开发、制造和供应诊断产品、医学成像系统和外科产品，通过早期发现和治疗来保护妇女的健康。它通过四个部分运作：诊断、乳房健康、妇科外科和骨骼健康。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Hologic (HOLX)
- 2 Casino Stocks Worth Taking a Look At
- This Small-Cap Healthcare Name Is Outperforming Its Index
- What Cintas Can Teach Investors About This Bear Market?
- Blackberry Stock Declines As Results Come In Lukewarm Once Again
- A Trio of Q3 Winners With Room to Run
- 免费获取StockNews.com关于霍洛奇的研究报告(HOLX)
- 值得一看的2只赌场股票
- 这家小盘股医疗保健公司的表现好于其指数
- 关于这个熊市，Cintas能教给投资者什么？
- 黑莓股价下跌，业绩再次不温不火
- 第三季度赢家三人组还有运行的空间
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.
接受《荷兰语日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对霍洛奇及相关公司的最新新闻和分析师评级的每日简要摘要。